PARP inhibitors

C3 Pill - yellow oval, 16mm

Generic Name: rucaparib

Pill with imprint C3 is Yellow, Oval and has been identified as Rubraca 300 mg. It is supplied by Clovis Oncology, Inc.

Rubraca is used in the treatment of Ovarian Cancer; Prostate Cancer and belongs to the drug class PARP inhibitors. Rubraca 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rubraca (Rucaparib [ roo-kap-a-rib ])-C3-300 mg-Yellow-Oval

Rubraca
Generic Name: rucaparib [ roo-kap-a-rib ]
Imprint: C3
Strength: 300 mg
Color: Yellow
Size: 16.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: PARP inhibitors
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 69660-0203
Inactive Ingredients: Microcrystalline cellulose, Sodium starch glycolate type A potato, Silicon dioxide, Magnesium stearate, Titanium dioxide, Magnesium silicate, Ferric oxide yellow,
Latest News
Related Drugs